1. Home
  2. VLRS vs ARVN Comparison

VLRS vs ARVN Comparison

Compare VLRS & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Controladora Vuela Compania de Aviacion S.A.B. de C.V.

VLRS

Controladora Vuela Compania de Aviacion S.A.B. de C.V.

HOLD

Current Price

$5.72

Market Cap

675.9M

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$7.72

Market Cap

600.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VLRS
ARVN
Founded
2005
2015
Country
Mexico
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
675.9M
600.2M
IPO Year
2013
2018

Fundamental Metrics

Financial Performance
Metric
VLRS
ARVN
Price
$5.72
$7.72
Analyst Decision
Buy
Buy
Analyst Count
14
16
Target Price
$9.04
★ $13.93
AVG Volume (30 Days)
383.6K
★ 650.9K
Earning Date
10-26-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 58.84
EPS
N/A
★ 1.70
Revenue
N/A
★ $262,600,000.00
Revenue This Year
$20.91
$12.76
Revenue Next Year
$7.79
N/A
P/E Ratio
★ N/A
$4.45
Revenue Growth
★ N/A
N/A
52 Week Low
$5.59
$6.74
52 Week High
$10.80
$14.22

Technical Indicators

Market Signals
Indicator
VLRS
ARVN
Relative Strength Index (RSI) 28.24 50.95
Support Level N/A $6.74
Resistance Level $7.15 $7.74
Average True Range (ATR) 0.21 0.34
MACD -0.04 0.09
Stochastic Oscillator 14.71 91.90

Price Performance

Historical Comparison
VLRS
ARVN

About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.

Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Share on Social Networks: